Cirrhosis and Portal Hypertension Gastroenterology Teaching Project American Gastroenterological Association

Similar documents
MANAGEMENT OF LIVER CIRRHOSIS: PRACTICE ESSENTIALS AND PATIENT SELF-MANAGEMENT

DISCLOSURES. This activity is jointly provided by Northwest Portland Area Indian Health Board and Cardea

Liver failure &portal hypertension

DISEASE LEVEL MEDICAL EVIDENCE PROTOCOL

PORTAL HYPERTENSION An Introduction to the Culprit of Many Liver Failure Complications

Etiology of liver cirrhosis

PORTAL HYPERTENSION. Tianjin Medical University LIU JIAN

Ascites Management. Atif Zaman, MD MPH Oregon Health & Science University Professor of Medicine Division of Gastroenterology and Hepatology

Steps in Assessing Fibrosis 4/30/2015. Overview of Liver Disease Associated With HCV

WEEK. MPharm Programme. Liver Biochemistry. Slide 1 of 49 MPHM14 Liver Biochemistry

Management of Chronic Liver Failure/Cirrhosis Complications in Hospitals. By: Dr. Kevin Dolehide

Interpreting Your Tests

Liver Failure. The most severe clinical consequence of liver disease is liver failure:

Assessment of Liver Function: Implications for HCC Treatment

Evaluation of Clinical, Biochemical and Ultrasound Parameters in Diagnosis of Oesophageal Varices

The Liver for the Nonhepatologist

End-Stage Liver Disease (ESLD): A Guide for HIV Physicians

International Journal of Pharma and Bio Sciences AN INTERESTING CASE OF SUBACUTE BUDD-CHIARI SYNDROME ABSTRACT

Investigating the patient with ascites

Definition: fibrosis and nodular regeneration resulting from hepatocellular injury

Laboratory Tests and Diagnostic Procedures in Liver Disease: Adventures in Liverland

INCREASED resistance to blood flow in the liver or portal venous system results

ESLD a Guide for HIV Physicians. Marion Peters University of California San Francisco June 2015

Jaundice. Agnieszka Dobrowolska- Zachwieja, MD, PhD

Approach to the Patient with Liver Disease

CHAPTER 1. Alcoholic Liver Disease

Module 1 Introduction of hepatitis

Tranjugular Intrahepatic Portosystemic Shunt

Hepatology for the Nonhepatologist

Hepatocytes produce. Proteins Clotting factors Hormones. Bile Flow

Learning Objectives. After attending this presentation, participants will be able to:

following the last documented transfusion; thereafter, evaluate the residual impairment(s).

King s College Hospital NHS Foundation Trust. Acute Liver Disease: what you really need to know.

Prognosis of untreated Primary Sclerosing Cholangitis (PSC) Erik Christensen Copenhagen, Denmark

The Yellow Patient. Dr Chiradeep Raychaudhuri, Consultant Hepatologist, Hull University Teaching Hospitals NHS Trust

Treating patients with end-stage liver disease: Are we ready? Dr. Mino R. Mitri, M.D., C.M., M.Ed., FRCPC

Medicine. Differential Clinical Impact of Ascites in Cirrhosis and Idiopathic Portal Hypertension

EDUCATION PRACTICE. Management of Refractory Ascites. Clinical Scenario. The Problem

Diagnostic Procedures. Measurement of Hepatic venous pressure in management of cirrhosis. Clinician s opinion

Hepatocellular Carcinoma: Diagnosis and Management

Hepatic sinusoidal obstruction syndrome due to herbal ingestion in South African children - An 8 year review

Atan Baas Sinuhaji Sub Division of Pediatrics Gastroentero-Hepatology Department of Childhealth,School of Medicine University of Sumatera Utara /

Management of Cirrhosis Related Complications

Podcast (Video Recorded Lecture Series): Portal HTN and Derivatives for the USMLE Step One Exam. Ultrasound (w/ doppler) Reversal of flow Portal Vein

ABIM Review Hepatobiliary

B C Outlines. Child-Pugh scores

European. Young Hepatologists Workshop. Organized by : Quantification of fibrosis and cirrhosis outcomes

World Health Organization. Western Pacific Region

The Liver for the Nonhepatologist

Liver Diseases. Yasmine Lashine MD, PhD

New York State HCV Provider Webinar Series

Initial Evaluation for HCV Therapy. Hope McGratty PA-C, MPH

Anatomy Jessica Ferguson Ashley Dobos May 31, 2006 LIVER

Pretreatment Evaluation

Diseases of liver. Dr. Mohamed. A. Mahdi 4/2/2019. Mob:

Original Article PLATELET COUNT TO SPLEEN DIAMETER RATIO AS A PREDICTOR OF ESOPHAGEAL VARICES IN PATIENTS OF LIVER CIRRHOSIS DUE TO HEPATITIS C VIRUS

Supplemental Appendix. 1. Protocol Definition of Sustained Virologic Response. A patient has a sustained virologic response if:

Pretreatment Evaluation

Contraindications. Indications. Complications. Currently TIPS is considered second or third line therapy for:

ABIM Review Hepatology

A A U

Transmission of HCV in the United States (CDC estimate)

Detection of Esophageal Varices in Liver Cirrhosis Using Non-invasive Parameters

Resident Teaching Conference:

Investigations before OLT, Immunosuppression and rejection, Follow up after OLT.

A Review of Liver Function Tests. James Gray Gastroenterology Vancouver

Evaluation of liver and spleen stiffness using a ultrasound guided method: Accuracy of ARFI(R) measurements in liver disease patients

Review: How to work up your patient with Hepatitis C

Noncirrhotic Portal Hypertension and Pathology of the Sinusoids. Ian R. Wanless Department of Pathology Dalhousie University Halifax, Canada

CIRROSI E IPERTENSIONE PORTALE NELLA DONNA

Approved regimens for cirrhotic patients

Life After SVR for Cirrhotic HCV

Evaluation of liver and spleen stiffness using a ultrasound guided method: Accuracy of ARFI(R) measurements in liver disease patients

ABNORMAL LIVER FUNCTION TESTS. Dr Uthayanan Chelvaratnam Hepatology Consultant North Bristol NHS Trust

Successful Treatment of Hepatic Venocclusive Disease in a Bone Marrow Transplant Patient With Side-to-Side Portacaval Shunt

ABIM Review Hepatobiliary

Transjugular Intrahepatic

LIVER, PANCREAS, AND BILIARY TRACT

Conflict of interest disclosures. Complications of end stage liver disease. None. The many complications of Cirrhosis. Portal Hypertension.

MANAGING END STAGE LIVER DISEASE IN RESOURCE LIMITED SETTINGS

2. Liver blood tests and what they mean p2 Acute and chronic liver screen

Portogram shows opacification of gastroesophageal varices.

Hepatology For The Nonhepatologist

Pulmonary Hypertension Complicating Hepatocellular Carcinoma

Intron A Hepatitis C. Intron A (interferon alfa-2b) Description

Denver Shunts vs TIPS for Ascites

New York State HCV Provider Webinar Series. Overview of Fibrosis Staging, Child s Pugh, MELD Scores

Management of the Cirrhotic Patient in the ICU

Clinical presentation and predictors of survival in patients with Budd Chiari Syndrome: Experience from a tertiary care hospital in Pakistan

Virtual Mentor American Medical Association Journal of Ethics December 2008, Volume 10, Number 12:

Barbara Rus Gadžijev Peter Popovič Klinični inštitut za radiologijo UKC Ljubljana

Chief infectionist of Kirov region Head of department in Kirov ID Hospital

Upper Gastrointestinal Bleeding Score for Differentiating Variceal and Nonvariceal Upper Gastrointestinal Bleeding ABSTRACT

Liver Transplantation Evaluation: Objectives

Management of Cirrhotic Complications Uncontrolled Ascites. Siwaporn Chainuvati, MD Siriraj Hospital Mahidol University

The Egyptian Journal of Hospital Medicine (July 2018) Vol. 72 (10), Page

Intron A (interferon alfa-2b) with ribavirin, (Moderiba, Rebetol, Ribasphere, RibaTab, ribavirin tablets/capsules - all strengths)

Chronic Hepatic Disease

Transcription:

CIRRHOSIS AND PORTAL HYPERTENSION Cirrhosis and Portal Hypertension Gastroenterology Teaching Project American Gastroenterological Association

WHAT IS CIRRHOSIS? What is Cirrhosis?

DEFINITION OF CIRRHOSIS Cirrhosis End stage of any chronic liver disease Characterized histologically by regenerative nodules surrounded by fibrous tissue Clinically there are two types of cirrhosis: Compensated Decompensated

GROSS IMAGE OF A NORMAL AND A CIRRHOTIC LIVER Normal Cirrhosis Irregular surface Nodules

HISTOLOGICAL IMAGE OF A NORMAL AND A CIRRHOTIC LIVER Normal Cirrhosis Nodules surrounded by fibrous tissue

WHAT IS THE NATURAL HISTORY OF CIRRHOSIS? What is the Natural History of Cirrhosis?

NATURAL HISTORY OF CHRONIC LIVER DISEASE Natural History of Chronic Liver Disease Chronic liver disease Compensated cirrhosis Decompensated cirrhosis Death Development of complications : Variceal hemorrhage Ascites Encephalopathy Jaundice

NATURAL HISTORY OF CIRRHOSIS Development of Complications in Compensated Cirrhosis 100 80 Probability of developing event 60 40 Ascites Jaundice Encephalopathy GI hemorrhage 20 0 0 20 40 60 80 100 120 140 160 Gines et. al., Hepatology 1987; 7:122 Months

SURVIVAL TIMES IN CIRRHOSIS Decompensation Shortens Survival 100 Probability of survival 80 60 40 All patients with cirrhosis Median survival ~ 9 years 20 0 0 20 Gines et. al., Hepatology 1987;7:122 Decompensated cirrhosis 40 60 80 100 120 140 160 Months Median survival ~ 1.6 years 180

COMPLICATIONS OF CIRRHOSIS Complications of Cirrhosis Result from Portal Hypertension or Liver Insufficiency Cirrhosis Portal hypertension Liver insufficiency Variceal hemorrhage Ascites Encephalopathy Spontaneous bacterial peritonitis Hepatorenal syndrome Jaundice

MECHANISMS OF PORTAL HYPERTENSION Most complications of cirrhosis result from portal hypertension. What mechanisms lead to portal hypertension?

DIAGNOSIS OF CIRRHOSIS Cirrhosis - Diagnosis Cirrhosis is a histological diagnosis However, in patients with chronic liver disease the presence of various clinical features suggests cirrhosis The presence of these clinical features can be followed by noninvasive testing, prior to liver biopsy

DIAGNOSIS OF CIRRHOSIS CLINICAL FINDINGS In Whom Should We Suspect Cirrhosis? Any patient with chronic liver disease Chronic abnormal aminotransferases and/or alkaline phosphatase Physical exam findings Stigmata of chronic liver disease (muscle wasting, vascular spiders, palmar erythema) Palpable left lobe of the liver Small liver span Splenomegaly Signs of decompensation (jaundice, ascites, asterixis)

DIAGNOSIS OF CIRRHOSIS LABORATORY STUDIES In Whom Should We Suspect Cirrhosis? Laboratory Liver insufficiency Low albumin (< 3.8 g/dl) Prolonged prothrombin time (INR > 1.3) High bilirubin (> 1.5 mg/dl) Portal hypertension Low platelet count (< 175 x1000/µl) AST / ALT ratio > 1

MECHANISMS OF PORTAL HYPERTENSION IN CIRRHOSIS In Cirrhosis: Increased intrahepatic resistance is the initial mechanism leading to portal hypertension

DIAGNOSIS OF CIRRHOSIS IMAGING STUDIES In Whom Should We Suspect Cirrhosis? Imaging studies Liver-spleen scan Small liver, irregular uptake Splenomegaly Colloid shift to bone marrow CAT scan / Ultrasound Nodular liver Splenomegaly Venous collaterals

DIAGNOSIS OF CIRRHOSIS LIVER-SPLEEN SCAN Liver-Spleen Scan Colloid shift to bone marrow and ribs Normal Cirrhosis Small liver, irregular uptake Splenomegaly

DIAGNOSIS OF CIRRHOSIS CAT SCAN CAT Scan in Cirrhosis Liver with an irregular surface Collaterals Splenomegaly

DIAGNOSIS OF CIRRHOSIS Confirmatory Liver Biopsy Is Not Always Necessary in Cirrhosis Liver biopsy is not necessary in the presence of any of the following: Decompensated cirrhosis (variceal hemorrhage, ascites, encephalopathy) Liver-spleen and/or CAT scan diagnostic of cirrhosis Liver biopsy is not necessary for pretransplant evaluation

NORMAL VASCULAR ANATOMY OF THE LIVER Normal Vascular Anatomy Hepatic Coronary Sinusoid Liver Inferior vena cava Portal Superior mesenteric Hepatic artery Splenic Inferior mesenteric

THE NORMAL LIVER OFFERS ALMOST NO RESISTANCE TO FLOW Normal Liver Hepatic Sinusoid Liver Portal Coronary Splenic

ARCHITECTURAL LIVER DISRUPTION IS THE MAIN MECHANISM THAT LEADS TO AN INCREASED INTRAHEPATIC RESISTANCE Cirrhotic Liver Portal systemic collaterals Distorted sinusoidal architecture leads to increased resistance Portal Splenomegaly

CAUSES OF PORTAL HYPERTENSION Causes of Portal Hypertension Cirrhosis is the most common cause of portal hypertension The site of increased resistance in cirrhosis is sinusoidal Other causes of portal hypertension are classified according to the site of increased resistance

CLASSIFICATION OF PORTAL HYPERTENSION Portal Hypertension Is Classified According to the Site of Increased Resistance Type Pre-hepatic Pre-sinusoidal Sinusoidal Post-sinusoidal Post-hepatic Example Portal or splenic thrombosis Schistosomiasis Cirrhosis Veno-occlusive disease Budd-Chiari syndrome

PRE-HEPATIC PORTAL HYPERTENSION Pre-Hepatic Portal Hypertension Hepatic Portosystemic collaterals Sinusoid Liver Thrombus Portal Splenomegaly

SINUSOIDAL PORTAL HYPERTENSION Sinusoidal Portal Hypertension Portal systemic collaterals Cirrhotic liver Portal Splenomegaly

POST-SINUSOIDAL PORTAL HYPERTENSION Post-Sinusoidal Portal Hypertension Portosystemic collaterals Sinusoid Centrilobular fibrosis Liver Portal Splenomegaly

POST-HEPATIC PORTAL HYPERTENSION Post-hepatic Portal Hypertension Thrombus Sinusoid Liver Portal Splenic